Dale S Edgerton

Vanderbilt University

$3,403,370

Attributed

$6,806,739

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.3M · FY2017–25

$2M$1.5M$1M$500K$0

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$6,806,739 · 3

By mechanism

R01$6,571,239 · 2

R56$235,500 · 1

Top collaborators

Alan D Cherrington11 shared

Most similar at Vanderbilt University

Same institution · by research overlap

Alan D Cherrington$25,582,234
Marcela Brissova$5,370,430
David Herlie Robertson$14,232,685
Owen P McGuinness$19,104,126
Libin Xu$7,729,917

Others in their field

Other Emerging Leaders on “Novel Therapeutic Intervention”

Leonard Freedman · Leidos Biomedical Research, Inc.$247,367,648
Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
Lynn Briscoe · Leidos Biomedical Research, Inc.$93,294,869
Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,912,072
Leonard Freedmand · Leidos Biomedical Research, Inc.$52,916,621
Kathleen Maletic Neuzil · Emory University$26,258,144

Research focus

Novel Therapeutic InterventionPhysiologicalInsulin ResistanceMuscleHyperinsulinismPeripheralGlucose ProductionGlucoseLiverGlucose UptakeGlucagonHyperglycemiaInsulinInfusion ProceduresAffectFatty Acid Glycerol EstersCanis FamiliarisExperimental StudyDiabetes MellitusHepaticBlood Glucose RegulationFastingFeedingPlay